feed,title,long_url,short_url
Benzinga,Agios' Rare Anemia Drug Application Under FDA Priority Review,https://benzinga.com/general/biotech/21/08/22552219/agios-rare-anemia-drug-application-under-fda-priority-review,https://j.mp/3xX5TSC
Benzinga,AnaptysBio-Generated Antibody Scores Second FDA Approval For Solid Tumor Indication,https://benzinga.com/general/biotech/21/08/22552040/anaptysbio-generated-antibody-scores-second-fda-approval-for-solid-tumor-indication,https://j.mp/3yZwkbJ
Benzinga,China's Tencent Clocks 20% Revenue Growth In Q2,https://benzinga.com/news/earnings/21/08/22552292/chinas-tencent-clocks-20-revenue-growth-in-q2,https://j.mp/3yXwnVb
